БОНСПРІ

Опис товару

About БОНСПРІ

БОНСПРІ is a prescription medication containing the active ingredient Ofatumumab, a monoclonal antibody used in the treatment of certain types of leukemia and lymphoma. It works by targeting and binding to specific proteins on the surface of cancer cells, leading to their destruction.

Key Benefits & Uses

• Treatment of relapsed or refractory chronic lymphocytic leukemia (CLL)
• Treatment of CLL with 17p deletion
• Treatment of follicular lymphoma

Active Ingredient & Action

Ofatumumab, the active ingredient in БОНСПРІ, is a recombinant humanized IgG1κ monoclonal antibody that targets the CD20 antigen on the surface of B cells. By binding to CD20, Ofatumumab triggers a series of cellular responses that ultimately lead to the destruction of cancer cells.

Important Notes

БОНСПРІ is available by prescription only and should be used under the guidance of a qualified healthcare professional. Patients with a history of severe allergic reactions, certain medical conditions, or taking certain medications may not be suitable candidates for treatment with БОНСПРІ. It is essential to follow the recommended dosage and administration instructions carefully to minimize the risk of adverse effects.